In an effort to ensure that Singaporeans receive quality healthcare at reasonable prices, Singapore’s Ministry of Health introduced the Medical Service Package (MSP) on July 2, 2004. The MSP, which took effect in all public institutions on July 5, 2004, will allow... Read More
On April 20, 2004, Singapore Health Sciences Authority (HSA) released a draft Bill to amend Singapore Medicines Act. The Bill will improve Singapore standing in the medical industry through better protection of pharmaceutical patents. It will also help attract more research-based pharmaceutical... Read More
The Singaporean government plans to institute new laws by the middle of 2004 to regulate the sale of health supplements in the country. This decision was made in response to two deaths, one of a local actress, occurring in 2002 as a... Read More
Effective January 1, 2004, the Singapore Health Sciences Authority (HSA) launched a consolidated Center for Drug Administration (CDA). The center was formed as a result of a merger between two of HSA’s former professional centers responsible for the regulation and evaluation of... Read More
In late October 2003, Singapore’s Ministry of Health announced the drafting of a new bill that would regulate research and collection of human stem cells and tissue. The draft law called the Regulation of Biomedical Research Bill has been placed on the... Read More
Singapore’s Health Sciences Authority (HSA) and China’s State Food and Drug Administration (SFDA) recently signed a Memorandum of Understanding (MOU) formalizing their agreement to further strengthen cooperation between the two government agencies. Both agencies are responsible for regulating drugs and health-related products... Read More
The ASEAN (Association of Southeast Asian Nations) Consultative Committee for Standards and Quality (ACCSQ) was formed in 1992 by the ASEAN Economic Ministers. The purpose of the committee is to eliminate technical barriers to trade and facilitate the objectives of the ASEAN... Read More
Singapore’s Health Sciences Authority (HSA) has been developing an electronic licensing system to support the regulatory functions of the Centre for Pharmaceutical Administration (CPA) since 2001. The HSA implemented the first part of its electronic system in April 15, 2003 with the... Read More
On May 14, 2002, Singapore’s Health Sciences Authority (HSA) and its Australian counterpart, the Therapeutic Goods Administration (TGA) signed a Memorandum of Intention of Cooperation (MOI) laying out its intentions to jointly collaborate and cooperate in their regulatory framework for pharmaceuticals, medical... Read More
The recent recall of over 200 health care products in Singapore has caused the Health Sciences Authority (HSA) to investigate ways to strengthen their regulatory control of health care products, particularly, health supplements. On May 9, 2003, the HSA recalled products produced... Read More